Willow Biosciences Inc. (WLLW.TO) Stock Price & Growth Analysis

Quote Panel

Updated October 28, 2024

1W 0.00 % 1M -14.29 % 3M -5.26 % 1Y 12.50 %

Key Metrics

Market Cap
12.98M
Shares Outstanding
144.20M
Share in Float
106.09M
Dividende
0

Earning Date
11 Nov 2024
Price Target
0.09
Average Volume
65777
Beta
1.127

Range
0.065-0.15
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.willowbio.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

7.05x

P/S Ratio

-208.23x

P/B Ratio

-25.1

Debt/Equity

-472.8%

Net Margin

$-0.1

EPS

How WLLW.TO compares to sector?

P/E Ratio

Relative Strength

WLLW.TO

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$263M

25573%

2025-Revenue

$263M

-23999%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q1.22

+106%

0.01
vs -0.10

Q2.22

N/A

-0.00
vs 0.05

Q3.22

N/A

-0.03
vs 0.03

Q4.22

N/A

-0.04
vs -0.05

Q1.23

N/A

-0.04
vs 0.01

Q2.23

N/A

-0.03
vs -0.00

Q3.23

N/A

-0.02
vs -0.03

Q4.23

N/A

-0.02
vs -0.04

Q1.24

N/A

-0.02
vs -0.04

Q2.24

N/A

-0.01
vs -0.03

Sales Growth

YoY

Current

Estimates

Q1.22

-100%

NA vs 6K

Q2.22

+126%

262K vs 116K

Q3.22

+2350%

49K vs 2K

Q4.22

+5567%

510K vs 9K

Q1.23

274K vs NA

Q2.23

-48%

135K vs 262K

Q3.23

+1276%

674K vs 49K

Q4.23

-83%

89K vs 510K

Q1.24

-81%

51K vs 274K

Q2.24

+660%

1M vs 135K

Return on Equity

QoQ

Q3.22

-19%

-0.19
vs -0.02

Q4.22

-29%

-0.29
vs -0.19

Q1.23

-40%

-0.40
vs -0.29

Q2.23

-44%

-0.44
vs -0.40

Q3.23

-39%

-0.39
vs -0.44

Q4.23

-71%

-0.71
vs -0.39

Q1.24

-153%

-1.53
vs -0.71

Q2.24

+3067%

30.67
vs -1.53

Institutionnal Ownership

QoQ

Q4.20

1
vs NA

Q1.21

1
vs 1

Q2.21

1
vs 1

Q3.21

1
vs 1

Q4.21

1
vs 1

Q2.23

1
vs NA

Company Description

N/A

7.05x

-208.23x

-25.1

-472.8%

$-0.1

$263M

$263M

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!